Latham & Watkins Reps Boston Scientific In $1.3B Deal

Law360, New York (March 8, 2012, 9:25 PM EST) -- Boston Scientific Corp. will pay up to $1.3 billion to buy California-based Cameron Health Inc., strengthening its arrhythmia management portfolio with the addition of the only commercially available subcutaneous implantable cardioverter-defibrillator, the buyer said Thursday.

Narick, Mass.-based Boston Scientific said it would exercise its option to buy the privately held company with an upfront payment of $150 million, plus a potential $150 million additional payment upon U.S. Food and Drug Administration approval of the subcutaneous defibrillator system. It will pay up to another $1.05 billion based...
To view the full article, register now.